Overview

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if albiglutide is safe and effective in the treatment of type 2 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Glimepiride
Glucagon-Like Peptide 1
Metformin
rGLP-1 protein
Sitagliptin Phosphate